Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...
The overall survival rate at 5 years was 13.4% for patients with sarcomatoid differentiation and 23.3% for patients without it. A large study suggests that patients with metastatic renal cell ...
Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming the prognosis for men whose disease has already progressed during or after docetaxel ...
Metastatic lung cancer is cancer that has spread (metastasized) from the lungs to other parts of the body, such as the liver or brain. While early-stage lung cancer is often asymptomatic (without ...
By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...
Nephrotoxicity risks vary among first-line treatment regimens for metastatic renal cell carcinoma (RCC), according to a meta-analysis presented in a poster at IKCS: North America 2024. The analysis ...